Oncolytic Viruses: A Promising Solution for Relapse Prevention after Autologous Hematopoietic Stem Cell Transplantation
Autologous hematopoietic stem cell transplantation (AHSCT) is widely used as a successful treatment in many hematopoietic cancers. However, one of the main challenges of AHSCT is the relapse of the disease which occurs mainly due to tumor contamination of autologous grafts or remaining cancer cells...
Main Authors: | Sayeh Parkhideh, Ronak Nalini, Mohammad Hossein Kazemi, Zeinab Kaboli, Elham Roshandel |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2021-07-01
|
Series: | Journal of Mazandaran University of Medical Sciences |
Subjects: | |
Online Access: | http://jmums.mazums.ac.ir/article-1-16241-en.html |
Similar Items
-
Post‐hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors
by: Elham Roshandel, et al.
Published: (2022-03-01) -
The association of disease type, pre-transplant hemoglobin level and platelet count with transfusion requirement after autologous hematopoietic stem cell transplantation
by: Shabnam Tabasi, et al.
Published: (2021-09-01) -
Outcomes in relapsed Hodgkin's lymphoma treated with autologous and allogeneic hematopoietic cell transplantation at the Pontificia Universidad Católica de Chile
by: Pablo Ramirez, et al.
Published: (2015-06-01) -
Finding the Optimal Conditioning Regimen for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation: A Retrospective Comparison of BEAM and High-Dose ICE
by: Onur Esbah, et al.
Published: (2016-08-01) -
Case Report: Lessons Learned From Subsequent Autologous and Allogeneic Hematopoietic Stem Cell Transplantations in a Pediatric Patient With Relapsing Polychondritis
by: Saskia R. Veldkamp, et al.
Published: (2022-03-01)